Indeed, melanoma cells with poor EGFR background are highly responsive to BRAF inhibitors, whereas colon carcinoma cells exhibit a rapid feedback activation of EGFR phosphorylation, being characterized by high EGFR expression [9]. The gene discussed is EGFR; the disease is melanoma.